Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of methylprednisolone aceponate cream and Bepanthenol Sensiderm in paediatric atopic dermatitis
2016-000409-35Phase 4Terminated
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in atopic dermatitis (AD) comparing Methylprednisolone aceponate arm with Bepanthenol Sensiderm arm (2 arms). Primary endpoints: Exploratory clinical efficacy of methylprednisolone aceponate and Bepanthenol Sensiderm and Tolerability of methylprednisolone aceponate cream and Bepanthenol Sensiderm. Started Mar 2016; status: terminated.
02
Drugs
methylprednisolone aceponateBepanthenol Sensiderm
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2016-000409-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000409-35.